Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients

R S Flammia,D Lavigne,Z Tian,F Saad, U Anceschi, M Gallucci, C Leonardo, F Preisser,P Mandel,F K H Chun,P I Karakiewicz, G Delouya,D Taussky,B Hoeh

Clinical Oncology(2023)

引用 0|浏览9
暂无评分
摘要
•The trial effect is not apparent in prostate cancer patients treated with radiotherapy.•Trial participants receive lower radiation doses than non-participants.•High-risk trial participants receive longer ADT than non-participants.
更多
查看译文
关键词
Biochemical recurrence,EBRT,high risk,intermediate risk,prostate cancer,radiotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要